Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BREATHE 2: Enhanced vs Standard Outreach for Smoking Cessation
NCT05683821Phase 4Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Jul 2023
- Primary completion
- May 2025
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by University of Wisconsin–Madison. Primary endpoint: Smoking Treatment Initiation Within 12 Months of Enrollment. Started Jul 2023; status: completed.
Beyond the preview
Go deeper on NCT05683821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05683821.